Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIA1 | P42261 | 3/20 | 0.32 |
| ▸ | GRIA2 | P42262 | 3/20 | 0.32 |
| ▸ | GRIA3 | P42263 | 3/20 | 0.32 |
| ▸ | GRIA4 | P48058 | 3/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | MITF | O75030 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16420312 | 0.85 | GRIA1 (0.33) | GRIA1GRIA2GRIA3GRIA4 | |
| SCHEMBL19749036 | 0.81 | ALDH1A1 (0.42) | ALDH1A1MAPTLMNATP53ALOX12 | |
| SCHEMBL16420337 | 0.78 | KDM4E (0.32) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL26140621 | 0.78 | ELANE (0.38) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL16727561 | 0.78 | ELANE (0.38) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL16525690 | 0.76 | GRIA1 (0.38) | GRIA1GRIA2GRIA3GRIA4ALDH1A1 | |
| SCHEMBL25518180 | 0.76 | ALDH1A1 (0.39) | ALDH1A1MAPTMITFLMNAMAPK1 | |
| SCHEMBL21074291 | 0.73 | ALDH1A1 (0.37) | ALDH1A1MAPTLMNAALOX15TSHR | |
| SCHEMBL17831016 | 0.73 | ALDH1A1 (0.37) | ALDH1A1MAPTLMNAALOX15TSHR | |
| SCHEMBL19999703 | 0.73 | ALDH1A1 (0.37) | ALDH1A1MAPTLMNAALOX15TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150280146-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2015-10-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150280146-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OXER1, SSB, RO60 | GRIA1 1249/4885GRIA2 2164/4885GRIA3 1179/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.